Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer
NCT04301557Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2020
- Primary completion
- Apr 2024
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started Jul 2020; status: active, not recruiting.
02
Drugs
toripalimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04301557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04301557.